» Articles » PMID: 17634369

Minocycline Alleviates Death of Oligodendrocytes by Inhibiting Pro-nerve Growth Factor Production in Microglia After Spinal Cord Injury

Overview
Journal J Neurosci
Specialty Neurology
Date 2007 Jul 20
PMID 17634369
Citations 111
Authors
Affiliations
Soon will be listed here.
Abstract

Spinal cord injury (SCI) causes a permanent neurological disability, and no satisfactory treatment is currently available. After SCI, pro-nerve growth factor (proNGF) is known to play a pivotal role in apoptosis of oligodendrocytes, but the cell types producing proNGF and the signaling pathways involved in proNGF production are primarily unknown. Here, we show that minocycline improves functional recovery after SCI in part by reducing apoptosis of oligodendrocytes via inhibition of proNGF production in microglia. After SCI, the stress-responsive p38 mitogen-activated protein kinase (p38MAPK) was activated only in microglia, and proNGF was produced by microglia via the p38MAPK-mediated pathway. Minocycline treatment significantly reduced proNGF production in microglia in vitro and in vivo by inhibition of the phosphorylation of p38MAPK. Furthermore, minocycline treatment inhibited p75 neurotrophin receptor expression and RhoA activation after injury. Finally, minocycline treatment inhibited oligodendrocyte death and improved functional recovery after SCI. These results suggest that minocycline may represent a potential therapeutic agent for acute SCI in humans.

Citing Articles

Potential role of ghrelin in neuroprotection and cognitive function: implications for diabetic cognitive impairment.

Zhang Y, Zhang R, Wang X, Shi L, Zhu H, Liu J PeerJ. 2025; 13:e18898.

PMID: 39995985 PMC: 11849504. DOI: 10.7717/peerj.18898.


Targeting Remyelination in Spinal Cord Injury: Insights and Emerging Therapeutic Strategies.

Al Mamun A, Quan Z, Geng P, Wang S, Shao C, Xiao J CNS Neurosci Ther. 2024; 30(12):1-15.

PMID: 39723448 PMC: 11669846. DOI: 10.1111/cns.70193.


Preparation of a minocycline polymer micelle thermosensitive gel and its application in spinal cord injury.

Gu J, Cai X, Raza F, Zafar H, Chu B, Yuan H Nanoscale Adv. 2024; .

PMID: 39355839 PMC: 11440374. DOI: 10.1039/d4na00625a.


Progression of mesenchymal stem cell regulation on imbalanced microenvironment after spinal cord injury.

Liu Y, Zhao C, Zhang R, Pang Y, Li L, Feng S Stem Cell Res Ther. 2024; 15(1):343.

PMID: 39354635 PMC: 11446099. DOI: 10.1186/s13287-024-03914-x.


TRPM7 Mediates Neuropathic Pain by Activating mTOR Signaling in Astrocytes after Spinal Cord Injury in Rats.

Kim I, Park C, Seo K, Lee J, Yune T Mol Neurobiol. 2024; 61(8):5265-5281.

PMID: 38180616 DOI: 10.1007/s12035-023-03888-6.


References
1.
Majdan M, Miller F . Neuronal life and death decisions functional antagonism between the Trk and p75 neurotrophin receptors. Int J Dev Neurosci. 1999; 17(3):153-61. DOI: 10.1016/s0736-5748(99)00016-7. View

2.
Yamashita T, Tucker K, Barde Y . Neurotrophin binding to the p75 receptor modulates Rho activity and axonal outgrowth. Neuron. 1999; 24(3):585-93. DOI: 10.1016/s0896-6273(00)81114-9. View

3.
Krenz N, Weaver L . Nerve growth factor in glia and inflammatory cells of the injured rat spinal cord. J Neurochem. 2000; 74(2):730-9. DOI: 10.1046/j.1471-4159.2000.740730.x. View

4.
Barrett G . The p75 neurotrophin receptor and neuronal apoptosis. Prog Neurobiol. 2000; 61(2):205-29. DOI: 10.1016/s0301-0082(99)00056-8. View

5.
Chen M, Ona V, Li M, Ferrante R, Fink K, Zhu S . Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med. 2000; 6(7):797-801. DOI: 10.1038/77528. View